- Q2 2024 Biora Therapeutics Inc Earnings Call TranscriptAug 12, 2024$0.5833 (-1.35%)Earnings
- Q1 2024 Biora Therapeutics Inc Earnings Call TranscriptMay 15, 2024$0.715 (-3.10%)Earnings
- Q4 2023 Biora Therapeutics Inc Earnings Call TranscriptMar 26, 2024$1.33 (+9.02%)Earnings
- Q3 2023 Biora Therapeutics Inc Earnings Call TranscriptNov 13, 2023$1.37 (-3.52%)Earnings
- Q2 2023 Biora Therapeutics Inc Earnings Call TranscriptAug 14, 2023$3.17 (-8.38%)Earnings
- Biora Therapeutics Inc Annual Shareholders Meeting TranscriptJun 14, 2023
- Q1 2023 Biora Therapeutics Inc Earnings Call TranscriptMay 15, 2023$3.35 (-10.90%)Earnings
- Q4 2022 Biora Therapeutics Inc Earnings Call TranscriptMar 30, 2023$2.67 (+0.75%)Earnings
- Biora Therapeutics Inc Extraordinary Shareholders Meeting TranscriptDec 19, 2022
- Q3 2022 Biora Therapeutics Inc Earnings Call TranscriptNov 14, 2022$7.03 (+0.75%)Earnings
- Q2 2022 Biora Therapeutics Inc Earnings Call TranscriptAug 15, 2022$26 (+4.00%)Earnings
- Biora Therapeutics Inc Annual Shareholders Meeting TranscriptJun 15, 2022
- Q1 2022 Biora Therapeutics Inc Earnings Call TranscriptMay 10, 2022$19.27 (+1.43%)Earnings
- Q4 2021 Progenity Inc Earnings Call TranscriptMar 28, 2022$40.25 (-4.73%)Earnings
- Q3 2021 Progenity Inc Earnings Call TranscriptNov 10, 2021$88 (+3.23%)Earnings
- Q2 2021 Progenity Inc Earnings Call TranscriptAug 12, 2021$43.5 (-3.87%)Earnings
- Progenity Inc at Raymond James Human Health Innovation Conference (Virtual) TranscriptJun 22, 2021
- Progenity Inc Call to Discuss Strategic Transformation TranscriptJun 02, 2021
- Q1 2021 Progenity Inc Earnings Call TranscriptMay 13, 2021$58.75 (-1.67%)Earnings
- Q4 2020 Progenity Inc Earnings Call TranscriptMar 18, 2021$109.75 (-11.85%)Earnings
- Progenity Inc Preeclampsia Virtual R&D Day TranscriptNov 20, 2020
- Q3 2020 Progenity Inc Earnings Call TranscriptNov 09, 2020$121.75 (-0.20%)Earnings
- Q2 2020 Progenity Inc Earnings Call TranscriptAug 13, 2020$223.75 (-1.97%)Earnings
Q4 2021 Progenity Inc Earnings Call Transcript
Greetings, and welcome to the Progenity Fourth Quarter and Full Year 2021 Earnings Call. (Operator Instructions)
As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Chuck Padala, Managing Director with LifeSci Advisors.
Thank you, operator. Good afternoon and welcome to Progenity's fourth quarter 2021 corporate update and financial results conference call. Joining me on the call are Aditya Mohanty, Chief Executive Officer of Progenity; and Eric d'Esparbes, Chief Financial Officer. Before I turn the call up to Mr. Mohanty, I would like to remind you that today's call will include forward-looking statements within the meaning of the federal securities laws, including, but not limited to, the types of statements identified as forward-looking statements in our annual report and Form 10-K that we will file later today and our subsequent periodic reports filed with the SEC, which will be available on our website in the Investors section. These forward-looking statements represent our views only as of the date
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)